SOX9 and chondrosarcoma: SOX9 expression was reduced by 36.6% in IL-1β-treated human chondrosarcoma cell line SW1353 and this downregulation was reversed dose dependently in the 20 μg/mL CZE and 0.4 μg/mL linarin treatments.